000 03962nam a22004575i 4500
001 978-1-4939-7445-0
003 DE-He213
005 20260610083640.0
007 cr nn 008mamaa
008 180503s2018 xxu| s |||| 0|eng d
020 _a9781493974450
_9978-1-4939-7445-0
024 7 _a10.1007/978-1-4939-7445-0
_2doi
050 4 _aRM300-666
072 7 _aMMG
_2bicssc
072 7 _aMED071000
_2bisacsh
072 7 _aMKG
_2thema
082 0 4 _a615
_223
245 1 0 _aIntegrin Targeting Systems for Tumor Diagnosis and Therapy
_h[electronic resource] /
_cedited by Eleonora Patsenker.
250 _a1st ed. 2018.
264 1 _aNew York, NY :
_bSpringer New York :
_bImprint: Humana,
_c2018.
300 _aXI, 226 p. 44 illus., 24 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aMethods in Pharmacology and Toxicology,
_x1940-6053
505 0 _aTumor Targeting by RGD-Grafted PLGA-Based Nanotheranostics Loaded with Paclitaxel and Superparamagnetic Iron Oxides -- Fabrication of cRGD Conjugated Dual Responsive Micelles to Target αvβ5 Integrin Overexpressed Cancer.- Copper-Free Click Chemistry Modification of Nanovectors for Integrin Targeted Cancer Therapy.- Preparation, Characterization, and In Vitro and In Vivo Evaluation of PEGylated Liposomal Doxorubicin Modified with Different cRGD Peptides -- Preparation of Heterobivalent and Multivalent Radiopharmarmaceuticals to Target Tumors Over-Expressing Integrins.- 177Lu Labeled RGD-BBN Peptide for Targeting Prostate Cancer -- Integrin-Mediated Targeting of Liposomally-Bound siRNAs to Tumor Vasculatures -- Integrin αvβ3-Targeted Optical Imaging with Metal Oxide Nanomaterials: Focusing on Zinc Oxide -- Integrin Targeting Using RGD-Based Peptide Amphiphiles -- Cyclic-RGDfK-Directed Docetaxel Loaded Nanomicelles for Angiogenic Tumor Targeting -- Targeting Glioma Cancer Cells with Fluorescent Nanodiamonds Via Integrin Receptors.- NIR Imaging-Guided Photothermal Therapy by cRGD-Conjugated Solid Lipid Nanoparticles Encapsulating IR-780 -- Synergistic Active Targeting to B16F10 Tumors by αvβ3/CD44-Targeted Nanoparticles Loaded with Docetaxel.
520 _aThis volume collects a variety of techniques and methodologies developed to facilitate research on integrin biology and to identify ideal targets and approaches for the treatment of multiple organ diseases, with a focus on cancer in particular. The chapters consecutively describe the tools for structural analysis, identification and detection of integrins as biomarkers, and include thorough laboratory and clinically-related methods on different strategies for generation, synthesis and evaluation of probes, carriers, peptides or small particles for integrin targeting, imaging, and drug delivery. As part of the Methods in Pharmacology and Toxicology series, this book contains the practical details that are invaluable in the laboratory.  Authoritative and advantageous, Integrin Targeting Systems for Tumor Diagnosis and Therapy serves readers from a wide spectrum, including researchers and students seeking an overview of existing developments, as well as leading professionals aiming to become more familiar with integrin-related innovative technologies in cancer research.
650 0 _aPharmacology.
650 1 4 _aPharmacology.
700 1 _aPatsenker, Eleonora.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9781493974436
776 0 8 _iPrinted edition:
_z9781493974443
776 0 8 _iPrinted edition:
_z9781493992478
830 0 _aMethods in Pharmacology and Toxicology,
_x1940-6053
856 4 0 _uhttps://doi.org/10.1007/978-1-4939-7445-0
912 _aZDB-2-PRO
999 _c6090
_d6090